pe
pep-05250 v1 CC-BY-SA-4.0

Moricin-2 cancer-fighting peptide

A peptide studied in the lab for its ability to fight cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length54 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.258
avg pLDDT49.6
ranking score0.449
STRUCTURE · PEP-05250 × ANTICANCER
ranking0.449
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence54 aa
1510152025303540455054
AMSLVSCSTAAPAKIPIK AIKTVGKAVGKGLRAINI ASTANDVFNFLKPKKRKH
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.4485081732273102 boltz-2
3-letter notation
Ala-Met-Ser-Leu-Val-Ser-Cys-Ser-Thr-Ala-Ala-Pro-Ala-Lys-Ile-Pro-Ile-Lys-Ala-Ile-Lys-Thr-Val-Gly-Lys-Ala-Val-Gly-Lys-Gly-Leu-Arg-Ala-Ile-Asn-Ile-Ala-Ser-Thr-Ala-Asn-Asp-Val-Phe-Asn-Phe-Leu-Lys-Pro-Lys-Lys-Arg-Lys-His
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Moricin-2 cancer-fighting peptide (pep-05250, v1). PeptideModel. https://peptidemodel.com/card/pep-05250
@peptide{pep05250,
  sequence = {AMSLVSCSTAAPAKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use